Angeli E,Rodríguez FM,Rey F .2019 .Liver fatty acid metabolism associations with reproductive performance of dairy cattle. Anim Reprod Sci, 208 : 106104.
Barnes PJ .2022 .Chemokine receptor CCR1: new target for asthma therapy. Trends Pharmacol Sci, 43 : 539-41.
Byun S,Seok S,Kim YC .2020 .Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase. Nat Commun, 11 : 807.
Chen CL,Lin YC .2022 .Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease:A New Therapeutic Target. Int J Mol Sci, 23 : 10055.
Cheng X,Ma X,Zhu Q .2019 .Pacer Is a Mediator of mTORC1 and GSK3-TIP60 Signaling in Regulation of Autophagosome Maturation and Lipid Metabolism. Mol Cell, 73 : 788-802.
Du C,Ma C,Geng R .2025 .Bruceine A inhibits TGF-β1/Smad pathway in pulmonary fibrosis by blocking gal3/TGF-β1 interaction. Phytomedicine, 136 : 156267.
Du X,Chen M,Fang Z .2024 .Evaluation of hepatic AMPK, mTORC1, and autophagy-lysosomal pathway in cows with mild or moderate fatty liver. J Dairy Sci, 107 : 3269-79.
Du X,Liu G,Loor JJ .2018 .Impaired hepatic autophagic activity in dairy cows with severe fatty liver is associated with inflammation and reduced liver function. J Dairy Sci, 101 : 11175-185.
Eng JM,Estall JL .1805 .Diet-Induced Models of Non-Alcoholic Fatty Liver Disease: Food for Thought on Sugar, Fat, and Cholesterol. Cells, 10 : .
Estes C,Razavi H,Loomba R .2018 .Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology, 67 : 123-33.
Filali-Mouncef Y,Hunter C,Roccio F .2022 .The ménage à trois of autophagy, lipid droplets and liver disease. Autophagy, 18 : 50-72.
Fujinaga H,Tsutsumi T,Yotsuyanagi H .2011 .HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species. Oncology, 81 : 11-17.
Gao Y,Zhang W,Zeng LQ .2020 .Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy. Redox Biol, 36 : 101635.
Gerloff BJ .2000 .Dry cow management for the prevention of ketosis and fatty liver in dairy cows. Vet Clin North Am Food Anim Pract, 16 : 283-92.
González-Gallego J,García-Mediavilla MV,Sánchez-Campos S .2011 .Hepatitis C virus, oxidative stress and steatosis: current status and perspectives. Curr Mol Med, 11 : 373-90.
Gross JJ .2023 .. Vet Clin North Am Food Anim Pract, 39 : 371-83.
Grummer RR .2008 .Nutritional and management strategies for the prevention of fatty liver in dairy cattle. Vet J, 176 : 10-20.
Hasan A,Repici A,Capra AP .2025 .CCR1 antagonist as a potential modulator of inflammatory, autophagic, and apoptotic markers in spinal cord injury. Neuropharmacology, 264 : 110239.
Huang Y,Zhang C,Sun X .2021 .Identification of differentially expressed miRNAs on normal cell, fatty liver cell and processed cell by monoammonium glycyrrhizinate from cattle (Bos indicus) by deep sequencing approach. Anim Biotechnol, 32 : 688-98.
Jakimowicz M,Szyda J,Jagusiak W .2025 .Genome-wide association study and enrichment analysis for clinical health traits in HolsteinFriesian cattle. Animal, 19 : 101545.
Jia Q,Cao H,Shen D .2019 .Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPARγ, LXRα and ABCA1. Int J Mol Med, 44 : 893-902.
Jiang Y,Chen D,Gong Q .2021 .- associated mitochondrial dysfunction and autophagy in nonalcoholic fatty liver disease. Lipids Health Dis, 20 : 40.
Le-Tian Z,Cheng-Zhang H,Xuan Z .2020 .Protein acetylation in mitochondria plays critical functions in the pathogenesis of fatty liver disease. BMC Genomics, 21 : 435.
Li H,Zhao X,Zheng L .2022 .Bruceine A protects against diabetic kidney disease via inhibiting galectin-1. Kidney Int, 102 : 521-35.
Lian CY,Zhai ZZ,Li Z,F Z .2020 .High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chem Biol Interact, 330 : 109199.
Lu W,Yang J,Hu M .2023 .Effects of choline deficiency and supplementation on lipid droplet accumulation in bovine primary liver cells in vitro. J Dairy Sci, 106 : 9868-78.
Nakao R,Mizukami C,Kawamura Y .2009 .Evaluation of efficacy of bruceine A, a natural quassinoid compound extracted from a medicinal plant, Brucea javanica, for canine babesiosis. J Vet Med Sci, 71 : 33-41.
Polyzos SA,Kountouras J,Mantzoros CS .2019 .Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism, 92 : 82-97.
Powell EE,Wong VW,Rinella M .2021 .Non-alcoholic fatty liver disease. Lancet, 397 : 2212-24.
Qiu J,Chen L,Zhang L .2023 .Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy. Phytomedicine, 121 : 155111.
Ren Q,Sun Q,Fu J .2024 .Dysfunction of autophagy in high-fat dietinduced non-alcoholic fatty liver disease. Autophagy, 20 : 221-41.
Shin SY,Lee DH,Lee J .2017 .C-C motif chemokine receptor 1 (CCR1) is a target of the EGF-AKT-mTOR-STAT3 signaling axis in breast cancer cells. Oncotarget, 8 : 94591-605.
Sun HM,Feng QY,Qin BF .2025 .Bruceine A attenuates fibrogenesis and inflammation through NR2F2-regulated HMGB1 inflammatory signaling cascades in hepatic fibrosis. Eur J Pharmacol, 987 : 177164.
Tanaka S,Hikita H,Tatsumi T .2016 .Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice. Hepatology, 64 : 1994-2014.
Terasaki M,Ono S,Hashimoto S .2022 .Suppression of C-C chemokine receptor 1 is a key regulation for colon cancer chemoprevention in AOM/DSS mice by fucoxanthin. J Nutr Biochem, 99 : 108871.
Tong J,Lan XT,Zhang Z .2023 .Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis. Acta Pharmacol Sin, 44 : 1014-28.
Tufarelli V,Puvača N,Glamočić D .2024 .The Most Important Metabolic Diseases in Dairy Cattle during the Transition Period. Animals (Basel), 14 : 816.
van Attekum MHA,Terpstra S,Slinger E .2017 .Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia. Oncogene, 36 : 3651-60.
Wang S,Zhang B,Mauck J .2024 .Diacylglycerol O-acyltransferase isoforms play a role in peridroplet mitochondrial fatty acid metabolism in bovine liver. J Dairy Sci, 107 : 9897-9914.
Wu X,Poulsen KL,Sanz-Garcia C .2020 .MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcoholassociated fatty liver and steatohepatitis. J Hepatol, 73 : 616-27.
Xu H,He Y,Chen S .2025 .Blocking the CCL5/CCL7-CCR1 axis regulates macrophage polarization through NF-κB pathway to alleviate the progression of osteoarthritis. Int Immunopharmacol, 147 : 114027.
Yan J,Zuo G,Sherchan P .2020 .CCR1 Activation Promotes Neuroinflammation Through CCR1/TPR1/ERK1/2 Signaling Pathway After Intracerebral Hemorrhage in Mice. Neurotherapeutics, 17 : 1170-83.
Yan LS,Zhang SF,Luo G .2022 .Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK/mTOR signaling pathway. Metabolism, 131 : 155200.
Younossi ZM .2019 .Non-alcoholic fatty liver disease-A global public health perspective. J Hepatol, 70 : 531-544.
Zhai T,Cai L,Jia X .2024 .IGFBP2 functions as an endogenous protector against hepatic steatosis via suppression of the EGFRSTAT3 pathway. Mol Metab, 89 : 102026.
Zhang C,Cao Y,Zuo Y .2023 .Bruceine a exerts antitumor effect against colon cancer by accumulating ROS and suppressing PI3K/Akt pathway. Front Pharmacol, 14 : 1149478.